Welcome, Guest
Username: Password: Remember me
  • Page:
  • 1

TOPIC:

Glecaprevir (NS3/4A) / Pibrentasvir (NS5A) equals Sof/Dac 5 years 5 months ago #24286

  • klhilde
  • klhilde's Avatar Topic Author
  • Offline
  • Elite Member
  • Elite Member
  • Posts: 253
  • Thank you received: 498
Phase III trials show 99% SVR in types 1,2,4,5,6 after 12 week treatment, and 95% for type 3 after 8 week treatment. These trials used no NS5B inhibitor. Imagine it in combo with Sofosbuvir.

finance.yahoo.com/news/abbvie-abbv-prese...-data-152503586.html

Why they keep doing 8 week trials, especially for type 3 patients, baffles me. These drugs' exorbitant prices do not come from their manufacturing cost ... therefore, drop the price by 1/3 and sell 50% more product, get the same revenue and stop screwing around with people's lives.

AbbVie on ENDURANCE-3:
news.abbvie.com/news/eight-weeks-treatme...onic-hepatitis-c.htm

AbbVie on EXPEDITION-1:
news.abbvie.com/news/abbvies-investigati...nsated-cirrhosis.htm
The following user(s) said Thank You: coral

Please Log in or Create an account to join the conversation.

Last edit: by klhilde.
  • Page:
  • 1
Time to create page: 0.038 seconds

Copyright © 2015-2020 FixHepC

Back to Top